Figure 1.
Six of the seven World Bank regions are organized according to geography. The seventh region, the High Income region (shown here in white) includes North America, Japan, Taiwan, Australia, New Zealand, and European countries–based on a gross national income greater than $12 276 per capita in 2010. Figure adapted from World Bank Regions, Disease Control Priorities Project. www.dcp2.org/page/main/BrowseCountries.html.
Table 1.
Use and annual initiation of renal replacement therapy.
Figure 2.
Regional income and use of RRT.
Correlation between income and use of RRT in World Bank Regions (Pearson’s r = 0.94). Income is reported as GNP in U.S. dollars per capita PPP from 2005. Abbreviations: RRT-renal replacement therapy, GNP-gross national income, PPP-purchasing power parity, ECA-Eastern Europe and Central Asia, LAC-Latin America and Caribbean, MNA-Middle East and North Africa, EAP-East Asia and Pacific, SA-South Asia and SSA-Sub-Saharan Africa.
Figure 3.
Annual initiation of RRT and use of RRT by modality.
Hemodialysis is the most commonly used therapy within developing regions. Transplants are relatively more commonly used and initiated therapies in MNA and SA regions. Peritoneal dialysis is relatively more commonly used and initiated in LAC. Abbreviations: RRT-Renal replacement therapy, HD-Hemodialysis, PD-Peritoneal dialysis, ECA-Eastern Europe and Central Asia, LAC-Latin America and Caribbean, MNA-Middle East and North Africa, EAP-East Asia and Pacific, SA-South Asia and SSA-Sub-saharan Africa.
Figure 4.
Proportion of diabetes, hypertension and glomerulonephritis among patients undergoing RRT.
Data for ECA are from registry data representing 60% of its population; for all other developing regions, data are from the most populous country within the region. Abbreviations: HD-Hemodialysis, PD-Peritoneal dialysis, ECA-Eastern Europe and Central Asia, LAC-Latin America and Caribbean, MNA-Middle East and North Africa, EAP-East Asia and Pacific, SA-South Asia and SSA-Sub-Saharan Africa.
Table 2.
Estimated incident ESRD and reported initiation of RRT in patients with diabetes and hypertension.
Table 3.
Estimates of first-year survival on renal replacement therapy.